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Abstract
Purpose Acute promyelocytic leukemia results from a
translocation between 15 and 17 chromosomes that pro-
duce PML/RARa fusion protein. PML/RARa inhibits dif-
ferentiation of myeloid precursor cells at stem cell level.
Resveratrol is a phytoalexin that exerts cytotoxic effects on
cancer cells. Ceramides have crucial roles in cell growth,
proliferation, differentiation, drug resistance, and apopto-
sis. In this study, we examined the possible cytotoxic
effects of resveratrol on acute myeloid leukemia cells and
determined the roles of ceramide-metabolizing genes in
resveratrol-induced apoptosis, in addition to investigating
the possibility of increasing the sensitivity of HL60 cells to
resveratrol by manipulating sphingolipids.
Methods Cytotoxic effects of resveratrol, C8:ceramide,
PDMP, and SK-1 inhibitor were determined by XTT cell
proliferation assay. Changes in caspase-3 enzyme activity
and mitochondrial membrane potential (MMP) were mea-
sured using caspase-3 colorimetric assay and JC-1 MMP
detection kit. Expression levels of ceramide-metabolizing
genes were examined by RT-PCR.
Results The results revealed that manipulations of cera-
mide metabolism toward generation or accumulation of
apoptotic ceramides increased apoptotic effects of resve-
ratrol in HL60 cells, synergistically. More importantly,
gene expression analyses revealed that resveratrol-induced
apoptosis via increasing expression levels of ceramide-
generating genes and decreasing expression levels of
antiapoptotic sphingosine kinase-1 and glucosylceramide
synthase genes.
Conclusion These results showed for the first time that
increasing intracellular levels of ceramides by biochemical
approaches has also increased sensitivity of HL60 cells to
resveratrol. We also showed that resveratrol induces
apoptosis through manipulating ceramide-metabolizing
genes that resulted in the accumulation of ceramides in
HL60 cells.
Keywords Ceramides  Bioactive sphingolipids 
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Introduction
Acute promyelocytic leukemia (APL) is a subtype of leu-
kemia that results from chromosomal translocation of
t(15;17) (q21;q22), which encodes promyelocytic leukemia
protein (PML)/retinoic acid receptor a (RARa) fusion
protein (Alcalay et al. 1992). PML is involved in control-
ling of genomic stability and tumor suppression, while
RARa binds to retinoic acid for differentiation of myeloid
cells. PML/RARa has an aberrant protein function acting
as a repressor of retinoic acid that induces differentiation of
myeloid cells (Lo-Coco and Ammatuna 2006). The pre-
valent therapy of acute myeloid leukemia is treatment
with all-trans retinoic acid (ATRA) and arsenic trioxide
(ATO) or a combination of them with some other agents
(Lengfelder et al. 2000). They bind to RARa receptor and
induce differentiation of myeloid cells. In addition to ATO
and ATRA, DNA methylase inhibitors, rexinoids, and his-
tone deacetylase inhibitors (HDACI) have also been used in
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the clinic (Vitoux et al. 2007). The natural products that
support the treatment of cancer have been given more
attention in the clinic recently.
Resveratrol (3,5,40-trans-trihydroxystilbene), is one of
the these natural products found in plant constitutes such as
grape skin, red wine, cranberries, blueberries, and peanuts
(Lee et al. 2008). It has shown significant cytotoxic and
apoptotic effect on various types of cancer cells with no
harm to normal healthy cells (Pirola and Frojdo 2008).
Resveratrol is synthesized from malonyl-CoA and p-cou-
maroyl-CoA molecules and yields 3,5,40-trans-trihydroxy-
stilbene trans-resveratrol in response to plant stress, UV
radiation, injury, and fungal infection (Baur and Sinclair
2006). It is a well-known phytochemical that acts as anti-
oxidant, anti-inflammatory, cardioprotective, and more
importantly has anti-tumor activities. Resveratol inhibits
tumor initiation, promotion, and progression (Jang et al.
1997; Sahin et al. 2007). However, the mechanism of
resveratrol-induced cell death is not well known.
Ceramide is a crucial signaling mediator in sphingolipid
metabolism, which is a key component in cell differentiation,
growth, proliferation, and apoptosis (Dagan et al. 2003). It
was recently demonstrated that de novo ceramide synthesis
is regulated by members of the mammalian longevity
assurance gene (LASS) family that are also known as cera-
mide synthase genes (D’Mello et al. 1994). Each gene is
responsible for the generation of different lengths of cera-
mides having different fatty acids (Pewzner-Jung et al.
2006). While LASS1 is responsible for the synthesis of C18-
ceramide (Venkataraman et al. 2002), LASS2 increased the
intracellular levels of C24-ceramides (Mizutani et al. 2005),
and LASS4 increased the levels of C22-ceramides (Riebeling
et al. 2003). C14- and C16-ceramides were synthesized by
LASS5 and LASS6 genes (Weinmann et al. 2005; Xu et al.
2005). It was shown by our group and by some others that
accumulation of ceramide in response to different stress
conditions, such as chemotherapeutics, radiation, and envi-
ronmental stress, leads to apoptosis and inhibition of cell
cycle progression in various types of cancer cells, while it
also increases the sensitivity of cancer cells to chemothera-
peutics (Phillips et al. 2007; Schenck et al. 2007).
Glucosylceramide synthase (GCS) enzyme transfers
glucose from UDP-glucose to ceramide and produces
glucosylceramide (Gouaze-Andersson and Cabot 2006).
Accumulation of glucosylceramide is a characteristic of
some multidrug-resistant cancer cells of leukemia, breast,
ovarian, and colon carcinomas (Liu and Wang 2008;
Ruckhaberle et al. 2009; Xie et al. 2008). On the other
hand, apoptotic ceramide can also be converted to anti-
apoptotic sphingosine-1-phosphate by sphingosine kinase-1
(SK-1) (Taha et al. 2006). Glucosylceramide and sphin-
gosine-1-phosphate promote cell growth and survival,
induce angiogenesis and metastasis, and inhibit apoptosis
(Ogretmen and Hannun 2004). Thus, targeting ceramide
metabolism toward generation and/or accumulation of
apoptotic ceramides may provide an important strategy for
the treatment of different types of cancers.
In this study, we have shown that resveratrol has cyto-
toxic and apoptotic effects on human HL60 acute myeloid
leukemia cells. More importantly, it was shown for the first
time by this study that resveratrol induces apoptosis
through increasing accumulation of ceramides by induction
of LASS genes and repression of SK-1 and GCS genes.
Materials and methods
Chemicals
Resveratrol was obtained from Sigma-Aldrich (USA).
A 10-mM stock solution of resveratrol was prepared with
DMSO and stored at -20C. C8:ceramide, N-(2-hydroxy-1-
(4-morpholinylmethyl)-2-phenylethyl)-decanamide, hydro-
chloride (PDMP), and SK-1 inhibitor were obtained from
Cayman Chemicals (USA), dissolved in DMSO, and stored
at -20C. The final concentration of DMSO did not exceed
more than 0.1% in culture. Primers were obtained from
Eurofins, Germany.
Cell lines and culture conditions
Human HL60 APL cells were kindly provided by Dr. Ali
Ugur Ural from Gulhane Military Medical School,
Department of Hematology. They were grown and main-
tained in RPMI1640 medium (Biological Industries, Israel)
containing 10% fetal bovine serum and 1% penicillin–
streptomycin (Invitrogen, USA) at 37C in 5% CO2.
Measurement of cell growth by XTT cell proliferation
assay
The IC50 values (drug concentration that inhibits cell
proliferation by 50%) of resveratrol, a ceramide analog,
C8:ceramide, and GCS enzyme inhibitor (PDMP), as well
as the IC10 value of SK-1 enzyme inhibitor were deter-
mined from cell proliferation plots obtained by XTT assay
as described (Gucluler and Baran 2009). Briefly,
2 9 104 cells were seeded into 96-well plates containing
200 ll growth medium in the absence or presence of
increasing concentrations of resveratrol, C8:ceramide,
PDMP, or SK-1 inhibitor. After 72 h of incubation in
5% CO2 incubator, they were treated with 40 ll of
XTT reagent for 4 h. Then, the absorbances of the samples
were measured under 490 nm wavelength of light by
Elisa reader (Thermo Electron Corporation Multiscan
Spectrum, Finland) and used for the cell proliferation plots.
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Finally, IC50 values of resveratrol, C8:ceramide, or PDMP,
and IC10 values of SK-1 inhibitor were calculated from cell
proliferation plots. To determine the possible synergistic
effects of resveratrol in combination with these ceramide
metabolism-manipulating chemicals, increasing concentra-
tions of resveratrol were applied together with IC50 value of
C8:ceramide or PDMP, or IC10 value of SK-1 inhibitor. The
same procedure of XTT cell proliferation assay was applied
for these set of experiments as mentioned above.
Measurements of caspase-3 enzyme activity
Changes in caspase-3 enzyme activities were determined
using caspase-3 colorimetric assay kit (R&D Systems,
USA) as described (Baran et al. 2007). As much as
1 9 106 cells were seeded in six-well plate in 2 ml growth
medium in the absence or presence of increasing concen-
trations of resveratrol, C8:ceramide, PDMP, or SK-1
inhibitor, or a combination of resveratrol with the others.
After 72 h of incubation in 5% CO2 incubator, the cells
were collected by centrifugation at 1,000g for 10 min. The
pellets were treated with 100 ll of cold lysis buffer (19) to
obtain the cell lysate. Then, the cell lysates were incubated
on ice for 10 min and centrifuged at 14,000g for 1 min.
Following the centrifugation, supernatants were transferred
to new Eppendorf tubes. For measuring caspase-3 enzyme
activity, reaction mixture including 50 ll of reaction buffer
(29), 50 ll of the samples, and 5 ll of caspase-3 colori-
metric substrate was applied to the cell suspensions in 96-
well plate and incubated for 2 h at 37C in 5% CO2
incubator. Absorbances of the samples were read under
405 nm wavelength of light via the ELISA reader (Thermo
Electron Corporation Multiskan Spectrum, Finland). Then
protein concentrations were measured by Bradford assay.
Finally, enzyme activity levels were normalized to protein
concentrations and determined by Bradford assay.
Detection of the loss of mitochondrial membrane
potential
The loss of mitochondrial membrane potential was detec-
ted by JC-1 mitochondrial membrane potential (MMP) kit
(Cell Technology, USA). As much as 1 9 106 cells were
seeded in six-well plate in 2 ml growth medium and treated
with different concentrations of resveratrol, C8:ceramide,
SK-1 inhibitor, or PDMP alone, or a combination of res-
veratrol with the others and incubated for 72 h. Treated
cells were collected by centrifugation at 1,000rpm for
10 min. Supernatants were removed and the pellets were
dissolved in 500 ll of JC-1 dye before their incubation at
37C in 5% CO2 for 15 min. Then, the mixtures were
centrifuged at 1,000g for 5 min. Pellets were resuspended
in 2 ml of blank media to remove excess dye and
centrifuged at 1,000rpm for 5 min. All pellets were
resuspended in 500 ll of blank media, and 150 ll from
each was added into black 96-well plate. The aggregate red
form of the dye, which is found in the inner mitochondria,
has an absorption/emission maxima of 585/590 nm and the
monomeric green form of the dye, which is released into
the cytoplasm due the loss of the MMP, has an absorption/
emission maxima of 510/527 nm. The plate was read at
these wavelengths by fluorescence Elisa reader (Thermo
Varioskan Spectrum, Finland). Finally, green/red (510/585)
values were calculated to determine the changes in MMP.
Total RNA isolation and RT-PCR
The expression levels of ceramide-metabolizing genes
were determined by reverse transcriptase-polymerase chain
reaction (RT-PCR). As much as 2 9 106 cells were seeded
in six-well plate in 3 ml growth medium and treated with
different concentrations of resveratrol for 72 h in 5% CO2.
Total RNA was extracted using a Nucleospin Total RNA
Isolation kit (Machery-Nagel, USA) as described by the
manufacturer. The amount and quality of RNA were
measured by Nanodrop Photospectrometer (NanoDrop
1000 THERMO, USA). As much as 5 lg of total RNA was
reverse transcribed into cDNA by reverse transcriptase
enzyme (Fermentas, USA). After incubation at 42C for
50 min, the reactions were stopped at 95C for 5 min. The
resulting total cDNA was then used to determine the
expression levels of LASS1, LASS2, LASS4, LASS5,
LASS6, SK-1, and GCS. Expression levels of b-actin were
used as internal positive control. The primer sequences
were as follows:
LASS1-F(50-CTATACATGGACACCTGGCGCAA-30),
LASS1-R(50-TCAGAAGCGCTTGTCCTTCACCA-30);
LASS2-F(50-GCTGGAGATTCACAT-30),
LASS2-R(50-GAAGACGATGAAGAT-30);
LASS4-F(50-TGCTGTCCAGTTTCAACGAG-30),
LASS4-R(50-GAGGAAGTGTTTCTCCAGCG-30);
LASS6-F(50CCTCGAGGGATGGATTACAAGGATGA
CGACGATAAGATGGCAGGG ATCTTAGCCTGG-30),
LASS6-R(50-CGGAATTCCGTTAATCATCCATG-
GAGCAGGA-30);
SK1-F(50-CCGACGAGGACTTTGTGCTAAT-30),
SK1-R(50-GCCTGTCCCCCCAAAGCATAAC-30);
GCS-F(50-ATGACAGAAAAAGTA-30),
GCS-R(5’-GGACACCCCTGAGTG-30); and
b-actin-F(50-CAGAGCAAGAGAGGCATCCT-30),
b-actin-R(50-TTGAAGGTCTCAAACATGAT-30) (Baran
et al. 2007).
Products of PCR reactions were visualized under UV after
running them on 2% agarose gel electrophoresis including
ethidium bromide at 90 V for 1 h.
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Results
Cytotoxic effects of resveratrol, C8:ceramide, SK-1
inhibitor, and PDMP on HL60 cells
There were dose-dependent cytotoxic effects of resveratrol,
C8:ceramide, PDMP, and SK-1 inhibitor on HL60 cells as
measured by XTT assay. IC50 values of resveratrol
(Fig. 1a), C8:ceramide (Fig. 1b), and PDMP (Fig. 1c) were
calculated from cell proliferation plots and found to be 75,
45, and 61 lM, respectively. IC10 value of SK-1 inhibitor
(Fig. 1d) was also calculated and found to be 5 lM.
Resveratrol in combination with C8:ceramide, PDMP,
or SK-1 inhibitor showed significant synergistic
cytotoxic effects on HL60 cells
There were 3, 5, 15, 29, and 45% decreases in cell pro-
liferation of HL60 cells in response to 1, 5, 10, 20, and
50 lM resveratrol, respectively (Fig. 1a). Combination of
the same concentrations of resveratrol with 45 lM
C8:ceramide, which induces de novo generation of cera-
mides, decreased cell proliferation by 75, 76, 80, 81, and
82%, respectively, as compared to untreated controls
(Fig. 2), while combination with 61 lM PDMP, which
provides accumulation of ceramides, resulted in 66, 71, 76,
88, and 89% decreases in proliferation of HL60 cells,
respectively (Fig. 2). Compared to untreated controls,
5 lM of SK-1 inhibitor in combination with the same
concentrations of resveratrol caused 19, 28, 39, 44, and
71% decreases in cell proliferation, respectively.
Changes in caspase-3 enzyme activity showed
synergistic apoptotic effects of resveratrol
with ceramide, PDMP, or SK-1 inhibitor as compared
to any agent alone
Caspase-3 enzyme activity was measured in HL60 cells
exposed to any agent alone or combinations of resveratrol/
C8:ceramide, resveratrol/PDMP, and resveratrol/SK-1
inhibitor. HL60 cells treated with 5 and 10 lM resveratrol
showed 1.11, and 1.14-fold increases in caspase-3 enzyme
activity as compared to untreated controls, while 45 lM
C8:ceramide, 61 lM PDMP, and 5 lM SK-1 inhibitor
resulted in 2.17, 1.81, and 1.71-fold increases in caspase-3
enzyme activity (Fig. 3). On the other hand, 5 lM resve-
ratrol in combination with the same concentrations of
C8:ceramide, PDMP, or SK-1 inihibitor resulted in 2.96,
2.62, and 2.45-fold increases in the enzyme activity,
respectively (Fig. 3). There were 3.77, 2.68, and 2.4-fold
increases in caspase-3 enzyme activity in HL60 cells
incubated with a combination of the same concentrations of
C8:ceramide, PDMP, or SK-1 inihibitor with 10 lM res-
veratrol, respectively (Fig. 3).
Effects of resveratrol alone and in combination
with C8:ceramide, PDMP, or SK-1 inhibitor on loss
of mitochondrial membrane potential
To confirm the caspase-3 enzyme activity results, we con-
ducted the same set of experiments to examine the changes in
mitochondrial membrane potential. The results revealed that
there were 1.37 and 1.45-fold increases in cytoplasmic/
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BFig. 1 Antiproliferative effects
of resveratrol (a), C8:ceramide
(b), PDMP (c), and SK-1
inhibitor (d) on HL60 cells.
The IC50 concentrations of
resveratrol, C8:ceramide,
and PDMP, as well as the IC10
value of SK-1 inhibitor were
calculated from cell
proliferation plots. The XTT
assays were performed using
triplicate samples in at least two
independent experiments. The
error bars represent the
standard deviations. Statistical
significance was determined
using two-way analysis of
variance, and p \ 0.05 was
considered to be significant
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mitochondrial JC-1 in response to 5 and 10 lM resveratrol,
respectively (Fig. 4). HL60 cells treated with 45 lM of
C8:ceramide, 61 lM of PDMP, or 5 lM of SK-1 inhibitor
showed 25.98, 1.18, or 10.29-fold increases in cytoplasmic/
mitochondrial JC-1. We applied a combination of 5 and
10 lM resveratrol together with the same doses of C8:cer-
amide, PDMP, or SK-1 inhibitor and observed 32.67 and
79.50-fold, 12.87 and 14.28-fold, or 1.75 and 2.41-fold
increases in cytoplasmic/mitochondrial JC-1, respectively,
as compared to untreated controls (Fig. 4).
Resveratrol induces de novo ceramide generation
and ceramide accumulation by increasing expression
levels of LASS genes and decreasing expression levels
of GCS and SK-1 genes
Expression levels of ceramide-metabolizing genes in HL60
cells treated with increasing concentrations of resveratrol
(1, 10, 20, and 50 lM) were determined by RT-PCR. The
results revealed that there were significant increases in
expression levels of LASS1, LASS2, LASS4, LASS5, and
LASS6 genes and decreases in expression levels of GCS
and SK-1 in a dose-dependent manner (Fig. 5). We quan-
tified expression levels of the genes and detected 1.5, 1.98,
1.79, 1.27, and 1.96-fold increases in expression levels of
LASS1, LASS2, LASS4, LASS5, and LASS6 and 0.5 and
0.6-fold decreases in expression levels of GCS and SK-1
genes, respectively, as normalized to b-actin levels and
compared to untreated controls (Fig. 5).
Discussion
There are different strategies for the treatment of acute
myeloid leukemia. But, significant problems are observed in
patients during treatment with these chemicals. Thus, natural
products that may have strong anticancer potential always
attract the attention of clinicians and basic science
researchers. In this study, we demonstrated anticancer
potentials of resveratrol on human acute myeloid leukemia
cells in addition to identifying a novel mechanism of res-
veratrol-induced apoptosis that involves bioactive sphingo-
lipids. On the other hand, we increased antiproliferative and
apoptotic effects of resveratrol on HL60 cells by targeting
ceramide-generating and ceramide clearance genes toward
generation and/or accumulation of apoptotic ceramides.
We have seen that resveratrol, C8:ceramide that induce
de novo generation of apoptotic ceramides, PDMP that
inhibits GCS enzyme, and SK-1 inhibitor showed cytotoxic
effects of HL60 cells in a dose-dependent manner. Res-
veratrol application resulted in increases in caspase-3
enzyme activity and loss of mitochondrial membrane
potential. Since the mitochondrial membrane potential and
caspases are downstream targets of ceramides, treatment of
HL60 cells with C8:ceramide, PDMP, or SK-1 inhibitor
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also resulted in increases in caspase-3 enzyme activity and
decreases in mitochondrial membrane potential. As we
manipulate the cells to increase intracellular generation or
accumulation of ceramides by biochemical approaches, we
observed significant synergistic cytotoxic effects of resve-
ratrol on HL60 cells. Combinations of resveratrol with
C8:ceramide, PDMP, or SK-1 inhibitor resulted in more
apoptotic cells as compared to any agent alone.
These findings were in agreement with literature. It was
shown that application of ceramide analogs or their
mimetics induces apoptosis and/or growth arrest in various
types of cancer cells (Bielawska et al. 2008; Szulc et al.
2006). It was clearly shown that there was significant
inhibition of tumor growth and progression in response to
ceramidoids, a recently synthesized ceramides, in head and
neck squamous cancer cells and some other cancer models,
in vivo (Bielawska et al. 2008; Senkal et al. 2006). Dif-
ferent structural analogs of ceramides have also been
shown to induce apoptosis in breast cancer cells (Struck-
hoff et al. 2004) and drug-resistant MCF-7/Adr cells
(Crawford et al. 2003). We have shown that increasing
expression levels of ceramide synthase gene (LASS1) in
imatinib-resistant and -sensitive K562 cells triggered
apoptosis and increased sensitivity of these cells to imati-
nib (Baran et al. 2007).
Targeting ceramide clearance enzymes is another
important strategy to increase intracellular concentrations
of ceramides (Ogretmen 2006). Inhibition of SK-1 enzyme
to block conversion of apoptotic ceramide to antiapoptotic
S1P is a novel treatment modality for the treatment of
cancers. It was shown in living animal models that inhi-
bition of SK-1 blocked cell growth and proliferation and
induced apoptosis (French et al. 2006). Inhibition of S1P
receptors or application of monoclonal antibodies against
S1P have also been shown to be effective protocols for the
treatment of cancers (Visentin et al. 2006). Our previous
data showed that partial inhibition of SK-1 by siRNA
resulted in apoptosis in imatinib-resistant K562 chronic
myeloid leukemia cells (Baran et al. 2007).
Glucosylceramide synthase enzyme has been shown to
be involved in drug resistance in cancer. Thus, inhibition of
GCS is also a novel treatment option for cancer cells.
Adriamycin-resistant MCF-7 cells showed sensitivity and
Fig. 4 Fold changes in
cytoplasmic/mitochondrial JC-1
in HL60 cells exposed to
combinations of resveratrol with
C8:ceramide, PDMP, or SK-1
inhibitor. The results are the
means of two independent
experiments. The error bars
represent the standard
deviations, and when not seen
they are smaller than the
thickness of the lines on the
graphs. p \ 0.05 was
considered to be significant
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Fig. 5 mRNA levels of ceramide-metabolizing genes in response to
resveratrol in HL60 cells. After 1, 10, 20, and 50 lM resveratrol were
applied to HL60 cells for 72 h, expression levels of ceramide-
metabolizing genes were determined by RT-PCR. Expression levels
of b-actin was detected as an internal positive control
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underwent apoptosis in response to GCS inhibitors, while
overexpression of GCS in MCF-7 cells resulted in multi-
drug resistance to several agents (Liu et al. 1999; Zhang
et al. 1997). Moreover, combination of GCS inhibitor with
some anticancer agents, such as doxorubicin, tamoxifen,
vincristine, and taxol, induced apoptosis synergistically
in various human cancer cells (Morjani et al. 2001;
Senchenkov et al. 2001).
Interestingly, our RT-PCR results showed that there
were significant increases in the expression levels of
LASS1, LASS2, LASS4, LASS5, and LASS6 genes in
response to resveratrol in a dose-dependent manner in
HL60 cells. In parallel studies, we have also detected sig-
nificant decreases in expression levels of SK-1 and GCS in
a dose-dependent manner in HL60 cells. Increased
expression of LASS genes (ceramide synthase) in response
to chemotherapeutic stress has also been shown in different
cancer cells. There was increased ceramide synthase enzyme
activity in response to daunarubicine and etoposide (Bose
and Kolesnick 2000; Perry et al. 2000). A camptohotecine
derivative CPT-11 and hexadevylephosphocholine agents
also induced apoptosis by upregulating ceramide synthase
genes (Wieder et al. 1998).
Taken together, these results showed for the first time
that resveratrol induces apoptosis through both increasing
de novo generation of apoptotic ceramides and decreasing
conversion of apoptotic ceramides to antiapoptotic sphin-
gosine-1-phosphate and glucosylceramide. On the other,
our data strongly suggest that targeting ceramide metabo-
lism increased chemosentivity of acute myeloid leukemia
cells to resveratrol. Since ceramides are the regulators of
vitally important biological processes, targeting ceramide-
metabolizing genes and their end products may be an
important avenue for the treatment of different types of
cancers.
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